iTeos Therapeutics targets the tumor microenvironment to boost immune cell efficiency in cancer eradication.

Immunotherapy is a revolutionary approach to cancer treatment that aims to educate the...

ExeVir Bio is a clinical stage company harnessing its VHH technology platform to generate robust antiviral therapies providing broad protection against viral infections, including coronaviruses. It is...

Syndesi Therapeutics is building upon a rich legacy of research on SV2A conducted at UCB. UCB identified novel modulators of SV2A that show pro-cognitive properties in preclinical models.

With the...